Formula Systems
✦ Quant Fair Value how this is computed
- Implied fair-value range of 383.21-1,074.54, from this stock's own trailing 5-year average P/E applied to trailing EPS.
- Current price is -85.0% below the average-multiple fair value of 728.87.
Valuation each multiple against its own 5-year range
Vs. peers Information Technology Services
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Formula Systems (FORTY) | 1.68B | 2.75 | 1.39 | 0.95% |
| IBM Corp (IBM) | 212.12B | 19.10 | 5.97 | 3.00% |
| Accenture (ACN) | 131.82B | 16.31 | 4.18 | 2.95% |
| Infosys (INFY) | 48.73B | 15.04 | 4.72 | 4.36% |
| Fiserv (FISV) | 29.73B | -7.56 | 1.41 | 0.00% |
| Cognizant (CTSH) | 25.95B | 10.59 | 1.76 | 2.24% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 16.9% below Morningstar's fair value estimate.
Fair value
Formula Systems (1985) Ltd receives a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 8% discount to our quantitative fair value estimate of $128.20 per share; however, some caution is warranted due to this estimate's medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.
The firm's valuation metrics increase our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to EBITDA ratio of 4.8, which falls in the bottom 20% compared with global peers. Relative to the company's EBITDA, the enterprise value of the business is low, which contributes to our view that shares are undervalued.
The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 164.5%, a core component of profitability, sits in the top 30% compared with peers globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:15 · For reference only, not investment advice and not tailored to your situation.
Formula Systems discussion 0 comments